Excelent. Cashflow and profit on the rise.
Sounds like we can expect a good pipeline of products:
"Regulatory expenses of $0.14M continue to significantly weigh on the accounts as we approach final approval stages for a number
of our products. Regulatory will remain a significant part of our operating focus and costs as we continue to bring new products
to market."
Sounds like we continue to be judicious with spending too:
"As a risk mitigation strategy, management have introduced focused control of non-essential spending."
Sounds like all expenses are good expenses. Sounds like management is responsible and capable. Worthy of holding for the long term.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable